Latest News - Milestones

Thursday, November 09, 2017 | Dry Eye, Milestones, Johnson & Johnson Vision Care, TearScience

Johnson & Johnson Vision Announces TearScience LipiScan and LipiFlow Now Available in More Than 800 Eye Care Practices

TearScience, now a part of Johnson & Johnson Vision, announced at the American Academy of Ophthalmology (AAO) 2017 Meeting that its LipiScan and LipiFlow technologies are now available in more tha…

Read the full story

Thursday, November 09, 2017 | Milestones, Avedro

One Year After Launch in the US, Avedro Updates Progress of Corneal Cross-Linking Treatment

Avedro marked the 1-year anniversary of the U.S. commercial availability of Photrexa Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa (riboflavin 5’-phosph…

Read the full story

Thursday, November 09, 2017 | Milestones

CheckedUp Reaches Adoption Milestone in Vision Care and Closes Bridge Financing

CheckedUp announced that installations of its patient engagement platform have increased significantly, with more than 15% of U.S. ophthalmic surgeons as adopters of the solution. The growth trajector…

Read the full story

Tuesday, October 10, 2017 | Milestones

California Optometric Association Champions Bill to Expand Optometric Practice in California

Over the weekend, Governor Jerry Brown signed AB 443, a bill championed by the California Optometric Association (COA) to improve eye care access for Californians. The bill, authored by Assembly Membe…

Read the full story

Thursday, September 28, 2017 | Milestones, Refractive IOL, Carl Zeiss Meditec

Zeiss Announces Completion of 1 Million SMILE Laser Vision Correction Procedures

The Medical Technology business group of Zeiss announced that doctors performing laser vision correction surgery using its SMILE refractive technology have now surpassed 1 million procedures worldwide…

Read the full story

Thursday, July 27, 2017 | Milestones, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Patent-Pending Dropless and LessDrops Formulations Exceed One Million Patient Eyes Milestone

Imprimis Pharmaceuticals announced that its core patent-pending ophthalmic formulations have now served more than 1 million patient eyes. Imprimis first began offering ophthalmic solutions to physicia…

Read the full story